Clinical Trial Update: HDL-Atherosclerosis Treatment Study (HATS) [Phase 3]

View source ↗

Summary

Phase 3 HDL-Atherosclerosis Treatment Study (HATS) has completed its trial status according to clinicaltrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Heart Disease
• Myocardial Ischemia

Drugs mentioned

• HDL-Atherosclerosis Treatment

Snippet

Sponsor: University of Washington | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED